Bio-Techne Corp (TECH)

Receivables turnover

		Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Revenue (ttm)	US$ in thousands	1,159,360	1,137,352	1,130,708	1,131,664	1,137,169	1,125,274	1,120,378	1,117,527	1,094,290	1,064,304	1,017,313	971,607	917,080	837,177	786,479	745,873	724,111	739,941	729,495	718,184
Receivables	US$ in thousands	241,394	227,887	207,451	204,570	218,468	216,415	184,763	174,174	194,548	202,095	152,896	147,548	145,385	157,790	128,243	122,635	122,534	117,452	111,753	122,724
Receivables turnover		4.80	4.99	5.45	5.53	5.21	5.20	6.06	6.42	5.62	5.27	6.65	6.59	6.31	5.31	6.13	6.08	5.91	6.30	6.53	5.85

June 30, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $1,159,360K ÷ $241,394K
= 4.80

The receivables turnover ratio for Bio-Techne Corp has shown some fluctuations over the past few quarters. It indicates how efficiently the company is able to collect cash from its credit sales within a given period.

In general, a higher receivables turnover ratio is preferable as it suggests that the company is collecting cash from its customers more quickly. A lower ratio may indicate issues with collections and potential liquidity problems.

Looking at the trend for Bio-Techne Corp, the receivables turnover ratio has been fluctuating between 4.80 and 6.65 over the last few quarters. While there is variability, the ratio has generally stayed within a relatively healthy range. The highest ratio of 6.65 was recorded in the first quarter of 2022, indicating efficient collection of receivables during that period.

It's important to monitor this ratio over time to see if there are any persistent trends or significant deviations from the historical range. Overall, Bio-Techne Corp's receivables turnover ratio reflects a reasonable efficiency in collecting cash from its credit sales.